A phase IB clinical trial to define assays and methods to be used for evaluating potential correlates of immunity following administration of the Merck Adenovirus serotype 5 HIV-1 gag/pol/nef vaccine in healthy, HIV-1 uninfected adult participants
Trial Details:
Ib
Terminated
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN)